Drugs / Symbicort Turbuhaler
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT02093195 Background | Dec 2013 → Dec 2015 | chronic obstructive pulmonary disease | Air Force Military Medical University, China | Unknown | No outcome recorded |
| Phase 3 | NCT00536731 Comparator | Sep 2007 → Apr 2008 | asthma | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Symbicort Turbuhaler | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00536731 ↗ |
| Route | Inhaled | “Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily” NCT00536731 ↗ |